Global Medical Alpha Radionuclide Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Medical Alpha Radionuclide Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.

According to our (Global Info Research) latest study, the global Medical Alpha Radionuclide market size was valued at US$ 3376 million in 2023 and is forecast to a readjusted size of USD 8113 million by 2030 with a CAGR of 14.3% during review period.

This report is a detailed and comprehensive analysis for global Medical Alpha Radionuclide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Medical Alpha Radionuclide market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030

Global Medical Alpha Radionuclide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030

Global Medical Alpha Radionuclide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030

Global Medical Alpha Radionuclide market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Medical Alpha Radionuclide

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Medical Alpha Radionuclide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler, Ionetix, Orano Med, National Nuclear Laboratory, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Medical Alpha Radionuclide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others

Market segment by Application
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours

Major players covered
ORNL
Tri-Lab
SSC RF-IPPE
JRC Karlsruhe
TerraPower
TRIUMF
Eckert&Ziegler
Ionetix
Orano Med
National Nuclear Laboratory
NorthStar

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Medical Alpha Radionuclide product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Medical Alpha Radionuclide, with price, sales quantity, revenue, and global market share of Medical Alpha Radionuclide from 2019 to 2024.

Chapter 3, the Medical Alpha Radionuclide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Medical Alpha Radionuclide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Medical Alpha Radionuclide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Alpha Radionuclide.

Chapter 14 and 15, to describe Medical Alpha Radionuclide sales channel, distributors, customers, research findings and conclusion.